Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Donghua Jinlong Chemical is a prominent Chinese manufacturer specializing in the production of glycine and its derivatives. Established in 1979, the company has grown into one of the world's largest producers of glycine, offering industrial, food, and pharmaceutical-grade products. Their high-purity glycine is utilized extensively in the pharmaceutical industry as an excipient and a key intermediate for drug synthesis. Beyond glycine, the company produces related chemicals such as hydantoin and sodium glycinate to support global supply chains. Donghua Jinlong maintains rigorous quality standards, including GMP certifications, to serve international markets in healthcare, agriculture, and food science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Donghua Jinlong Chemical.